Original Contributions |
From the Departments of Pathology (P.P.S., M.S.A., M.B.M., K.E.B.) and Medicine (J.B.H.), Emory University School of Medicine, Atlanta, Ga.
Correspondence to Kenneth E. Bernstein, MD, Department of Pathology, Emory University School of Medicine, 1639 Pierce Dr, 7107 WMB, Atlanta, GA 30322. E-mail kbernst{at}emory.edu
Abstractp130Cas is a
signaling molecule that was initially found to be
tyrosine-phosphorylated in v-Crk and v-Src transformed
cells. We characterized the regulation of p130Cas tyrosine
phosphorylation in vascular smooth muscle cells by
angiotensin II (Ang II). This ligand induced a transient
increase in p130Cas tyrosine
phosphorylation, which was sensitive to the actin
polymerization inhibitor cytochalasin D and to the
intracellular Ca2+ chelator BAPTA-AM but not the
Ca2+ channel blocker verapamil. The Ang
IIinduced tyrosine phosphorylation of
p130Cas was also dependent on an active Src family tyrosine
kinase, since it could be blocked by the Src kinase
inhibitors geldanamycin and PP1. Ang II treatment resulted
in the ability of p130Cas to bind at least 11 different
phosphate-containing proteins. Analysis of these proteins
revealed that protein kinase C
and the cell adhesion signaling
molecule pp120 formed temporal associations with p130Cas in
response to Ang II. c-Src was found to associate with
p130Cas in a manner that was independent of Ang II
treatment. Inhibition of protein kinase C by either calphostin C or
phorbol 12-myristate 13-acetate downregulation inhibited the
Ang IIinduced tyrosine phosphorylation of
p130Cas. These results are the first to demonstrate that
the tyrosine phosphorylation of p130Cas by
Ang II is transduced by the Src, intracellular Ca2+,
protein kinase C signaling pathway.
Key Words: p130Cas tyrosine phosphorylation angiotensin II vascular smooth muscle cell
This article has been cited by other articles:
![]() |
M. D. Godeny and P. P. Sayeski ANG II-induced cell proliferation is dually mediated by c-Src/Yes/Fyn-regulated ERK1/2 activation in the cytoplasm and PKC{zeta}-controlled ERK1/2 activity within the nucleus Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1297 - C1307. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Godeny and P. P. Sayeski ERK1/2 regulates ANG II-dependent cell proliferation via cytoplasmic activation of RSK2 and nuclear activation of elk1 Am J Physiol Cell Physiol, December 1, 2006; 291(6): C1308 - C1317. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-J. Park, K. Boyd, and T. Curran Cardiovascular and Craniofacial Defects in Crk-Null Mice. Mol. Cell. Biol., August 1, 2006; 26(16): 6272 - 6282. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Wallace, D. VonDerLinden, K. He, S. J. Frank, and P. P. Sayeski Microarray analyses identify JAK2 tyrosine kinase as a key mediator of ligand-independent gene expression Am J Physiol Cell Physiol, October 1, 2004; 287(4): C981 - C991. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sandberg and P. P. Sayeski Jak2 Tyrosine Kinase Mediates Oxidative Stress-induced Apoptosis in Vascular Smooth Muscle Cells J. Biol. Chem., August 13, 2004; 279(33): 34547 - 34552. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kyaw, M. Yoshizumi, K. Tsuchiya, S. Kagami, Y. Izawa, Y. Fujita, N. Ali, Y. Kanematsu, K. Toida, K. Ishimura, et al. Src and Cas Are Essentially but Differentially Involved in Angiotensin II-Stimulated Migration of Vascular Smooth Muscle Cells via Extracellular Signal-Regulated Kinase 1/2 and c-Jun NH2-Terminal Kinase Activation Mol. Pharmacol., April 1, 2004; 65(4): 832 - 841. [Abstract] [Full Text] |
||||
![]() |
B. Callaghan, S.D. Koh, and K.D. Keef Muscarinic M2 Receptor Stimulation of Cav1.2b Requires Phosphatidylinositol 3-Kinase, Protein Kinase C, and c-Src Circ. Res., March 19, 2004; 94(5): 626 - 633. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sandberg, X. Ma, D. VonDerLinden, M. D. Godeny, and P. P. Sayeski Jak2 Tyrosine Kinase Mediates Angiotensin II-dependent Inactivation of ERK2 via Induction of Mitogen-activated Protein Kinase Phosphatase 1 J. Biol. Chem., January 16, 2004; 279(3): 1956 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kodama, K. Fukuda, E. Takahashi, S. Tahara, Y. Tomita, M. Ieda, K. Kimura, K. M. Owada, K. Vuori, and S. Ogawa Selective Involvement of p130Cas/Crk/Pyk2/c-Src in Endothelin-1-Induced JNK Activation Hypertension, June 1, 2003; 41(6): 1372 - 1379. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Berry, R. Touyz, A. F. Dominiczak, R. C. Webb, and D. G. Johns Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide Am J Physiol Heart Circ Physiol, December 1, 2001; 281(6): H2337 - H2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. James, A. Ingram, H. Ly, K. Thai, L. Cai, and J. W. Scholey Angiotensin II activates the GFAT promoter in mesangial cells Am J Physiol Renal Physiol, July 1, 2001; 281(1): F151 - F162. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Rocic, G. Govindarajan, A. Sabri, and P. A. Lucchesi A role for PYK2 in regulation of ERK1/2 MAP kinases and PI 3-kinase by ANG II in vascular smooth muscle Am J Physiol Cell Physiol, January 1, 2001; 280(1): C90 - C99. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Touyz and E. L. Schiffrin Signal Transduction Mechanisms Mediating the Physiological and Pathophysiological Actions of Angiotensin II in Vascular Smooth Muscle Cells Pharmacol. Rev., December 1, 2000; 52(4): 639 - 672. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Hall, C. M. Matter, X. Wang, and G. H. Gibbons Hyperglycemia Inhibits Vascular Smooth Muscle Cell Apoptosis Through a Protein Kinase C-Dependent Pathway Circ. Res., September 29, 2000; 87(7): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Haendeler, M. Ishida, L. Hunyady, and B. C. Berk The Third Cytoplasmic Loop of the Angiotensin II Type 1 Receptor Exerts Differential Effects on Extracellular Signal-Regulated Kinase (ERK1/ERK2) and Apoptosis via Ras- and Rap1-Dependent Pathways Circ. Res., April 14, 2000; 86(7): 729 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tang, Z. J. Zhao, E. J. Landon, and T. Inagami Regulation of Calcium-sensitive Tyrosine Kinase Pyk2 by Angiotensin II in Endothelial Cells. ROLES OF Yes TYROSINE KINASE AND TYROSINE PHOSPHATASE SHP-2 J. Biol. Chem., March 17, 2000; 275(12): 8389 - 8396. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kim and H. Iwao Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases Pharmacol. Rev., March 1, 2000; 52(1): 11 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Sayeski, M. S. Ali, A. Safavi, M. Lyles, S.-O. Kim, S. J. Frank, and K. E. Bernstein A Catalytically Active Jak2 Is Required for the Angiotensin II-dependent Activation of Fyn J. Biol. Chem., November 12, 1999; 274(46): 33131 - 33142. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Okuda, M. Takahashi, J. Suero, C. E. Murry, O. Traub, H. Kawakatsu, and B. C. Berk Shear Stress Stimulation of p130cas Tyrosine Phosphorylation Requires Calcium-dependent c-Src Activation J. Biol. Chem., September 17, 1999; 274(38): 26803 - 26809. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, L. Hernandez-Lagunas, W. C. Horne, and R. Baron Cytoskeleton-dependent Tyrosine Phosphorylation of the p130Cas Family Member HEF1 Downstream of the G Protein-coupled Calcitonin Receptor. CALCITONIN INDUCES THE ASSOCIATION OF HEF1, PAXILLIN, AND FOCAL ADHESION KINASE J. Biol. Chem., August 27, 1999; 274(35): 25093 - 25098. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Sayeski, M. S. Ali, K. Hawks, S. J. Frank, and K. E. Bernstein The Angiotensin II–Dependent Association of Jak2 and c-Src Requires the N-Terminus of Jak2 and the SH2 Domain of c-Src Circ. Res., June 11, 1999; 84(11): 1332 - 1338. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Sadoshima Versatility of the Angiotensin II Type 1 Receptor Circ. Res., June 29, 1998; 82(12): 1352 - 1355. [Full Text] [PDF] |
||||
![]() |
Z. Zhang, R. Baron, and W. C. Horne Integrin Engagement, the Actin Cytoskeleton, and c-Src Are Required for the Calcitonin-induced Tyrosine Phosphorylation of Paxillin and HEF1, but Not for Calcitonin-induced Erk1/2 Phosphorylation J. Biol. Chem., November 17, 2000; 275(47): 37219 - 37223. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohmori, Y. Yatomi, H. Okamoto, Y. Miura, G. Rile, K. Satoh, and Y. Ozaki Gi-mediated Cas Tyrosine Phosphorylation in Vascular Endothelial Cells Stimulated with Sphingosine 1-Phosphate. POSSIBLE INVOLVEMENT IN CELL MOTILITY ENHANCEMENT IN COOPERATION WITH Rho-MEDIATED PATHWAYS J. Biol. Chem., February 9, 2001; 276(7): 5274 - 5280. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Suzuki-Inoue, Y. Ozaki, M. Kainoh, Y. Shin, Y. Wu, Y. Yatomi, T. Ohmori, T. Tanaka, K. Satoh, and T. Morita Rhodocytin Induces Platelet Aggregation by Interacting with Glycoprotein Ia/IIa (GPIa/IIa, Integrin alpha 2beta 1). INVOLVEMENT OF GPIa/IIa-ASSOCIATED Src AND PROTEIN TYROSINE PHOSPHORYLATION J. Biol. Chem., January 5, 2001; 276(2): 1643 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Chung, J. Y. Sung, W. Ahn, H. Rhim, T. H. Oh, M. G. Lee, and Y. S. Ahn Intracellular Calcium Mobilization Induces Immediate Early Gene pip92 via Src and Mitogen-activated Protein Kinase in Immortalized Hippocampal Cells J. Biol. Chem., January 12, 2001; 276(3): 2132 - 2138. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |